Barclays »

Pasithea Therapeutics Corp shares owned by Barclays

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $138 269 0.52

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Pasithea Therapeutics Corp

Cable Car Capital
Stonepine Capital Management
Henderson Group
Adage Capital Partners GP
Jupiter Topco
Opaleye Management
Ameriprise Financial
Squadron Capital Management
AdvisorShares Investments
Vivo Capital
Persistent Asset Partners
UBS Group
XTX Topco
Vanguard Capital Management
Geode Capital Management

View all funds holding Pasithea Therapeutics Corp